What are the criteria that define acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Considered AKI

Acute kidney injury (AKI) is diagnosed when ANY ONE of the following KDIGO criteria is met: serum creatinine rises by ≥0.3 mg/dL within 48 hours, OR serum creatinine rises to ≥1.5 times baseline within 7 days, OR urine output falls below 0.5 mL/kg/h for more than 6 consecutive hours. 1

Core Diagnostic Criteria (KDIGO)

The diagnosis requires meeting any single criterion—you do not need all three 1:

  • Creatinine criterion #1: Absolute increase of ≥0.3 mg/dL (≥26 μmol/L) within any 48-hour period 1, 2
  • Creatinine criterion #2: Rise to ≥1.5× baseline (≥50% increase) within the prior 7 days 1, 2
  • Urine output criterion: <0.5 mL/kg/h for >6 consecutive hours 1, 2

Even the modest 0.3 mg/dL threshold is clinically significant—it independently associates with approximately 4-fold increased in-hospital mortality 1, 3.


AKI Staging (KDIGO)

Once AKI is diagnosed, stage it retrospectively using the most severe criterion met during the episode 1:

Stage Creatinine Criterion Urine Output Criterion
1 1.5–1.9× baseline OR increase ≥0.3 mg/dL <0.5 mL/kg/h for 6–12 h
2 2.0–2.9× baseline <0.5 mL/kg/h for ≥12 h
3 ≥3.0× baseline OR ≥4.0 mg/dL with acute rise ≥0.3 mg/dL OR initiation of dialysis <0.3 mL/kg/h for ≥24 h OR anuria ≥12 h

1, 3

Higher stages correlate strongly with increased mortality risk. 1


Establishing Baseline Creatinine

Use the most recent known creatinine value from the medical record within the prior 3 months—this is superior to any imputation method 1, 2. Search aggressively for outpatient labs, emergency-department visits, pre-operative assessments, and prior admissions 2.

  • If no prior value exists, admission creatinine serves as baseline 1
  • Do NOT back-calculate baseline using MDRD equations (assuming GFR 75 mL/min/1.73 m²) in patients with cirrhosis or populations with high CKD prevalence—this overestimates AKI incidence 1, 2

Special Populations: Cirrhosis & Ascites

In cirrhotic patients with ascites, rely exclusively on serum creatinine changes—ignore urine output criteria. 1, 2

  • These patients are frequently oliguric with avid sodium retention yet maintain relatively normal GFR 1, 2
  • Diuretic therapy further confounds urine output interpretation 1, 2
  • Volume expansion from ascites dilutes serum creatinine, lowering its concentration independent of true kidney function 1
  • A creatinine threshold ≥1.5 mg/dL predicts AKI progression and worse prognosis in this population 1

Common Pitfalls & Caveats

  • Serum creatinine limitations: Affected by muscle mass, age, sex, nutritional status, and hyperbilirubinemia (which interferes with colorimetric assays) 1. Massive fluid resuscitation can dilute creatinine, masking significant GFR reduction 1.

  • Urine output unreliability: Beyond cirrhosis, urine collection is often inaccurate in clinical practice and influenced by body weight, race, age, gender, and diuretic use 2. Do not rely on urine output alone in patients receiving diuretics 1.

  • Temporal detection: Monitor creatinine at 48-hour intervals to detect the 0.3 mg/dL threshold in real time 1. Do not wait for creatinine to reach 1.5 mg/dL—this outdated threshold often indicates GFR has already fallen to ~30 mL/min 1.

  • AKI on CKD: Apply the same KDIGO criteria relative to the patient's established CKD baseline 1. Even small acute rises meeting AKI thresholds confer markedly higher mortality (47% vs 19% for CKD alone) 1.


When to Consult Nephrology

Stage 2 or Stage 3 AKI warrants prompt nephrology involvement. 1

Additional indications include 4:

  • Inadequate response to supportive treatment
  • AKI without a clear cause
  • Pre-existing stage 4 or higher CKD
  • Need for renal replacement therapy

References

Guideline

Diagnóstico y Estadificación de Lesión Renal Aguda

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Kidney Injury Definition and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Kidney Injury Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Kidney Injury: Diagnosis and Management.

American family physician, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.